Table 2 Percentage of relevant features to discriminate benign from malignant lipomatous tumors
From: MRI-based radiomics to predict lipomatous soft tissue tumors malignancy: a pilot study
Benign vs. Malignant | |
|---|---|
Size | 100% (6/6) |
Shape | 80.0% (4/5) |
Intensity distribution | 28.6% (4/14) |
GLCM | 95.2% (20/21) |
GLRLM | 92.3% (12/13) |
GLSZM | 69.2% (9/13) |
NGTDM | 80.0% (4/5) |
Gabor filtering | 50.0% (5/10) |